Female Sexual Dysfunction – FSD



FSD or Female Sexual Dysfunction is a multi-faceted condition that involves components related to physiology, psychology, emotional aspects, spouse issues and social factors. Throughout the menopausal changeover phase, there is a significant plummet in a woman’s needs, libido, sexual receptiveness and regularity of sexual activity.

For health experts there is mostly scrubby time to delve into sexual issues and hence the significance of these issues could be often marginalised. Hence, it is apposite that the regular practise of including queries on sexuality be included as a part of a routine gynaecological history. The problems would then be categorised into lack of desire, lack of arousal or lack of orgasm.

Female Sexual Dysfunction Causes:

  • Both aging and dipping oestradiol levels were related to female sexual dysfunction (FSD).
  • Chronic ailments like heart disease, cancer, diabetes, autoimmune syndromes, thyroid dysfunction and neurological impediment could have an undue bearing on sexual function.
  • Psychological disarrays and marital discord; mate health and erectile function are also contributors to FSD.
  • The relation between lowered testosterone levels with aging is not that evidently related to sexual functioning though it is reckoned to play a role.
  • Deficit of oestrogen has been proven to have a strong link with lowered sexual function.
  • Certain medications have a negative impact on sexual function such as psychotropic medicines, several heart agents, anti-histamines and oral birth control pills.

Female Sexual Dysfunction Symptoms:

  • A decline in oestrogen additionally influences the brain centrally and is a major contributor to sleep disorders, mood fluctuations, fettered cognitive functioning and a rise in muscle aches and joint pains that can majorly affect well-being.
  • Dwindling libido and sexual responsiveness.

Female Sexual Dysfunction - FSDDiagnosis & Tests:

The doctor would take a precise sexual and gynaecological history and conduct a focused clinical assessment. A comprehensive evaluation is carried out into the medical and social history.

Clinical assessment would involve a pelvic examination for detecting signs and symptoms of genital alterations that might be contributors to sexual dysfunction like atropy, vaginitis, pain eliciting points, pelvic masses, vaginal or uterine prolapse and might include incontinence. Apprehensions regarding leakage during orgasm could be a factor in sexual dysfunction. The visualisation of the vaginal, vulval and cervical regions are essentially carried out to look into important pathology like neoplasms and prolapse.

Co-morbidities would additionally be investigated inclusive of thyroid, diabetes and heart risk factors.

A litmus paper test is carried out to check the pH level of the vagina. A vaginal pH more than 4.5 is an indicator of atrophic vaginitis. Though hot flushes might lower with time, atrophic vaginitis does not and could deteriorate with more vaginal shortening, persistent infections and rising dyspareunia.

Related Posts with Thumbnails

Popularity: 8% [?]

RSSComments (1)

Leave a Reply | Trackback URL

  1. vareeja says:

    A number of studies have explored the factors that contribute to female sexual arousal disorder and female orgasmic disorder. An existing drug, bremelanotide, has also been found to increase libido in 90% of subjects, and was being developed with the intention of selling as a treatment for sexual arousal disorder. Bremelanotide (formerly PT-141) was in clinical tests until 2007, but was pulled from further testing due to adverse effects to the cardiovascular system

Leave a Reply

CommentLuv badge